Form 4 for EYPT EyePoint, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0002013623-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-03 | EYPT | Ribeiro Ramiro | Chief Medical Off | F - Tax | $17.48 | -6,373 | 13.3K | -32% | -$111.4K |
| D | 2026-01-06 | 2026-01-03 | EYPT | Ribeiro Ramiro | Chief Medical Off | M - OptEx | $0.00 | +19.7K | 19.7K | New | $0 |
| DM | 2026-01-06 | 2026-01-02 | EYPT | Ribeiro Ramiro | Chief Medical Off | A - Grant | $0.00 | +257.1K | 171.4K | New | $0 |
| D | 2026-01-06 | 2026-01-03 | EYPT | Ribeiro Ramiro | Chief Medical Off | M - OptEx | $0.00 | -19.7K | 39.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-03 | F | D | 6,373 | $17.48 | 13,294 | D | — | — | (F1) No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. |
| 2 | Common | Common Stock | 2026-01-03 | M | A | 19,667 | $0.00 | 19,667 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-02 | A | A | 85,700 | $0.00 | 85,700 | D | $0.00 · — to — | 85,700 Common Stock | (F2) The restricted stock units will vest in three ratable annual installments beginning January 2, 2027. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-01-02 | A | A | 171,400 | $0.00 | 171,400 | D | $17.48 · — to 2036-01-02 | 171,400 Common Stock | (F3) The option to purchase will vest and become exercisable as follows: 25% at January 2, 2027 and the remainder ratably, on a monthly basis, over the remaining three years. |
| 5 | Derivative | Restricted Stock Units | 2026-01-03 | M | D | 19,667 | $0.00 | 39,333 | D | $0.00 · — to — | 19,667 Common Stock | (F4) The restricted stock units vest in three ratable annual installments beginning January 3, 2026. |